Quentin O’Brien, MPH
Orexo US, Inc.
Quentin O’Brien is a Medical Science Liaison at Orexo US, where her work focuses on Orexo’s digital therapeutics, which use artificial intelligence to deliver cognitive behavioral therapy to help individuals better cope with depression and substance use disorders. Quentin often collaborates with experts in clinical practice and research settings to advance the science of digital therapeutics for mental health. She also provides education to clinics and health care systems about how digital therapeutics can be integrated into various care models.
Quentin completed her Master of Public Health (MPH) degree at Columbia University before joining the pharmaceutical and medical device industries. During her MPH program, her research focused on delivering public health nutrition education via information and communication technologies in developing countries. Currently, she is finishing her PhD dissertation research at George Washington University. Her dissertation research aims to elucidate how social identity and digital equity interact to impact the therapeutic relationship during teletherapy.